Lomongo, Amonsot M.

HRN: 29-71-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/23/2026
03/30/2026
IVTT
1.5g
Q6H
CELLULITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: